Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history

Ratios

vs
industry
vs
history
P/E(ttm) 16.97
PID's P/E(ttm) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PID: 16.97 )
Ranked among companies with meaningful P/E(ttm) only.
PID' s P/E(ttm) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 18.04
Current: 16.97
0
18.04
PE(NRI) 16.97
PID's PE(NRI) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PID: 16.97 )
Ranked among companies with meaningful PE(NRI) only.
PID' s PE(NRI) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 18.04
Current: 16.97
0
18.04
P/B 1.61
PID's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PID: 1.61 )
Ranked among companies with meaningful P/B only.
PID' s P/B Range Over the Past 10 Years
Min: 0  Med: 0 Max: 1.62
Current: 1.61
0
1.62

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 4.04
PID's Dividend Yield is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PID: 4.04 )
Ranked among companies with meaningful Dividend Yield only.
PID' s Dividend Yield Range Over the Past 10 Years
Min: 0  Med: 0 Max: 4.19
Current: 4.04
0
4.19
Yield on cost (5-Year) 4.04
PID's Yield on cost (5-Year) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. PID: 4.04 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
PID' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 4.19
Current: 4.04
0
4.19

More Statistics

Short Percentage of Float0.00%
52-Week Range $11.44 - 14.98
Shares Outstanding (Mil)49,800,000.00
» More Articles for PID

Headlines

Articles On GuruFocus.com
Low-Priced Retail Stocks Gurus Shopped for Ahead of Holiday Season Dec 02 2016 
Barrick Repurchases $595 Million of Corporate Loan Dec 02 2016 
23 Questions With Bakul Lalla Dec 02 2016 
Qualcomm: Balance Sheet, Dividend Yield Make It Attractive Dec 02 2016 
Apple: A Dividend Achiever in the Making Dec 02 2016 
Neiman Marcus Debenture Bonds Yielding 8% Dec 02 2016 
Competitor Performance Is Eating Nike’s Lunch Dec 02 2016 
Smith & Wesson Reports Strong Quarter, but Stock Suffers Post Election Dec 02 2016 
6 Things That May Surprise You About Building Wealth Dec 02 2016 
Carl Icahn Takes 15% Stake in Enzon Pharmaceuticals Dec 02 2016 

More From Other Websites
PowerShares Announces Listing Transfer for 27 ETFs Nov 23 2016
How Sandoz Performed for Novartis in 3Q16 Nov 17 2016
How Tresiba Helps Novo Achieve Its Growth Targets Nov 03 2016
Victoza Dominates Global GLP-1 Class Nov 03 2016
Reading Novo’s Insulin Portfolio to Find Clues about Its Growth Nov 02 2016
US Still the Largest Market for Novo Nordisk Nov 01 2016
Why Did PotashCorp’s Nitrogen Prices Fall in 3Q16? Nov 01 2016
How Much Is the Return Opportunity for Novo Nordisk in 3Q16? Oct 25 2016
Novartis’s 3Q16 Estimates: Will Alcon Recover Its Growth? Oct 24 2016
Novartis’s 3Q16 Estimates: Innovative Medicines Segment Oct 24 2016
5 Best Smart Beta ETFs That Pay Dividends (PID, ICF) Oct 20 2016
Is the Dividend ETF Bull Run Over? Oct 07 2016
International Dividend ETFs Remain Solid Ideas Oct 06 2016
Novo Nordisk Expects to Witness Strong Growth from New Product Launches Oct 03 2016
Novo Nordisk Is Expected to See Strong Growth in Insulin Segment Sep 30 2016
Novo Nordisk Is Focusing on These Strategic Areas in 2016 Sep 29 2016
Teva’s Share of the US Generics Market Could Boost Its Stock Sep 28 2016
Winning? We Review How Teva Dominates Generic Drug Space Sep 26 2016
Sanofi’s Chase for Zika Virus Vaccine Could Drive Its Share Price Sep 15 2016
Will Sanofi See More Growth from Its Blockbuster Insulin Drug? Sep 15 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK